Zhou Fangzheng, Nie Long, Feng Dali, Guo Siyan, Luo Ren'Na
Department of Oncology, Suizhou Hospital, Hubei University of Medicine, Suizhou, Hubei 441399, P.R. China.
Department of Radiotherapy and Chemotherapy, The Second People's Hospital of Yichang, Yichang, Hubei 43000, P.R. China.
Oncol Rep. 2022 Jul;48(1). doi: 10.3892/or.2022.8339. Epub 2022 Jun 1.
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the cell migration and invasion assay data shown in Figs. 2F, 5D and 6D were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 38: 1857‑1866, 2017; DOI: 10.3892/or.2017.5835].
在本文发表后,一位关注此事的读者提醒编辑注意,图2F、5D和6D中所示的细胞迁移和侵袭试验数据与不同作者在其他文章中以不同形式出现的数据惊人地相似。由于上述文章中有争议的数据在提交给本期刊之前已在其他地方发表,或已在考虑发表,编辑决定将本文从本期刊撤回。在与作者联系后,他们同意撤回该论文的决定。编辑就由此造成的不便向读者致歉。[原文发表于《肿瘤学报道》38: 1857-1866,2017;DOI: 10.3892/or.2017.5835]